S, B. K., S, M., A, D., S, N., & R, N. (2026). Gut microbial metabolites targeting JUN in renal cell carcinoma via IL-17 signaling pathway: Network pharmacology approach. Molecular diversity, 30(1), 613. https://doi.org/10.1007/s11030-025-11188-5
Chicago Style (17th ed.) CitationS, Bala Kumar, Mishra S, Das A, Nag S, and Naidu R. "Gut Microbial Metabolites Targeting JUN in Renal Cell Carcinoma via IL-17 Signaling Pathway: Network Pharmacology Approach." Molecular Diversity 30, no. 1 (2026): 613. https://doi.org/10.1007/s11030-025-11188-5.
MLA (9th ed.) CitationS, Bala Kumar, et al. "Gut Microbial Metabolites Targeting JUN in Renal Cell Carcinoma via IL-17 Signaling Pathway: Network Pharmacology Approach." Molecular Diversity, vol. 30, no. 1, 2026, p. 613, https://doi.org/10.1007/s11030-025-11188-5.